Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create 'malaria resistant' mosquitos
Mosquito larvae
By using a gene editing tool called CRISPR, scientists were able to prevent malaria transmission being passed down to 99.5 per cent of offspring.
Findings offer hope for future elimination of the disease
 
US scientists say they have managed to create a genetically modified mosquito that can block malaria infection, preventing its ability to transmit the disease to humans.

While further work is needed, the discovery could one day help to eradicate a disease that kills nearly a million people every year.

Scientists from the University of California (UC) inserted DNA into the germ line of Anopheles stephensi mosquitos - a leading malaria vector in Asia.

This prevented malaria transmission being passed on to 99.5 per cent of the insects' progeny, according to results published in the journal PNAS.

The UC team used a gene editing tool called CRISPR, which allows access to the cell nucleus to snip DNA for replacing mutated genes or inserting new ones.

"This is a significant first step," said Anthony James, a distinguished professor from UC's Irvine campus. "We know the gene works. The mosquitoes we created are not the final brand, but we know this technology allows us to efficiently create large populations."

Malaria is one of the world's leading health concerns, affecting 300-500 million people every year. Over 40 per cent of the world's population live in areas where there is a risk of contracting the disease.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk